Navigation Links
Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Date:2/20/2008

n US dollars. All currency figures reported in this document, including comparative figures, are reported in US dollars, unless otherwise specified.

For the three-month period ended December 31, 2007, the net loss amounted to $16,097,000 ($0.33 per share), compared to $17,011,000 ($0.44 per share) for the corresponding period in the previous year. For the year ended December 31, 2007, the net loss amounted to $81,486,000 ($1.85 per share), compared to $66,469,000 ($1.72 per share) for the same period the previous year.

The net loss for the year ended December 31, 2007, includes a non-recurring charge in the second quarter of fiscal 2007 under Canadian GAAP of $10,430,000 relating to the $40 million 5% senior subordinated convertible notes, which were fully converted into common shares during the second quarter of 2007. In total, accretion expense amounted to $15,751,000 for the year ended December 31, 2007.

Revenue from collaboration agreement amounted to $206,000 for the current quarter ($1,119,000 for the year), compared to $497,000 for the same period in the previous year ($2,106,000 for the year). This revenue is earned under the agreement with Centocor, Inc. (Centocor) in respect of eprodisate (KIACTA(TM)), an oral investigational product candidate for the treatment of Amyloid A (AA) amyloidosis. Revenue recognized is in respect of the non-refundable upfront payment received from Centocor, which is being amortized over the estimated period through to the anticipated regulatory approval date of the investigational product candidate. The estimated period is subject to change based on additional information that the Company may receive periodically. The other portion of the upfront payment received from Centocor ($6,000,000) has been classified as deferred revenue and is not being amortized as earned revenue given that it is potentially refundable. In the event that the Company receives an approval letter issued by the US Food and Drug Adminis
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
3. Neurochem to present at JPMorgan Healthcare Conference
4. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
5. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
6. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
7. Neurochem reports results for third quarter of fiscal 2007
8. Emageon Reports Fourth Quarter and 2007 Financial Results
9. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
10. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... ZH Healthcare (ZH), ... today that Bill Lane, joins ZH’s Advisory Board. ... BlueEHS,a first of its kind, Freemium SaaS, Electronic ... Health Records (EHR) with an integrated practice management ... patient portal, and more. Combined with its Revenue ...
(Date:5/22/2015)... 22, 2015 Medivo, Inc., a leader in ... and Genotype Results in ‘Baby Boomers’ Screened for HCV Following ... Lab Test Database” at Digestive Disease Week, May 16-19, 2015. ... and Analytics team members Carol Smyth, MB; Jason Bhan, MD; ... MSI, along with Nancy Reau, MD from the University of ...
(Date:5/22/2015)... DMG Productions announces the upcoming airing ... on Friday, May 29, 2015 at 7:30 a.m. ET ... this episode Innovations will explore Interstate Restoration, a company ... through disaster recovery and restoration. , Additionally, the series ... to develop and deliver training and education in the ...
(Date:5/22/2015)... May 22, 2015 In April 2006, ... the past 9 years they have concentrated their focus ... States and Canada. Because of this growth and their ... corporate offices in Denver, Colorado, Cleveland, Ohio, Houston, Texas ... in opening new dental offices, dental start ups, orthodontic ...
(Date:5/22/2015)... 2015 Puritan Medical Products, a ... medical, diagnostic, environmental, and forensics industries celebrates 96 ... in the US. At a time when countless ... US, Puritan remains committed to designing and manufacturing ... Maine facility. , Since 1919, Puritan has focused ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2
... ... Essay Contest, Contest will reward winning caregivers with ... for a break for,America,s unsung heroes, the 50 million American caregivers who ... Number One resource for family caregivers., That,s why Caring Today magazine ...
... Political Accountability Major Part of Unprecedented ,Justice for,All, Plan ... than $150 million, mobilize tens of,thousands during and AFTER ... WASHINGTON, May 8 Members and leaders of ... hold elected,leaders strictly accountable if they say one thing ...
... to ease condition in water creature , , THURSDAY, May 8 ... Iraq War veterans, ringing in the ears is a condition ... Now, a researcher says he hopes to find a cure ... Moore, an audiologist and cell biologist at Northwestern University, said ...
... As injectable fillers,become mainstream it is no ... expensive alternatives to prevent facial wrinkles. Dr. Arnold,Klein, ... Hills says, "Fillers such as Artefill, Radiesse and ... injected into,human tissue, all of these products can ...
... The following is being,issued by the National Kidney Foundation ... including headlining sets from Staind and Live, as,well as ... of DC,101,s Last Band Standing Contest, The Blackjacks; top ... judges including America,s Next,Top Model finalist Sara Albert., ...
... Easily Detected and ... Treated, ... CEO of Susan G. Komen for the Cure(R),testified today before a special ... need for comprehensive legislation to,address the nation,s cancer crisis., (Logo: ...
Cached Medicine News:Health News:Do You Need a Caregiving Break Today? 2Health News:Do You Need a Caregiving Break Today? 3Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 2Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 3Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 4Health News:Secret to Treating Tinnitus in Vets May Be Unlocked in Zebrafish 2Health News:Dr. Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers 2Health News:Susan G. Komen for the Cure's(R) Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 2Health News:Susan G. Komen for the Cure's(R) Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 3
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), ... repair and regeneration, today announced that J.J. Finkelstein ... present a corporate overview at two upcoming investor conferences. ... SeeThruEquity 4 th Annual Microcap Conference on Thursday ... at 11:00 am EDT.  A webcast will ...
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma ... diagnosed victims of mesothelioma get the best possible ... certain individuals with this rare cancer caused by ... most up-to-date information related to treatment options such ... please call the Mesothelioma Victims Center anytime at ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: